We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Critical Care Analyzer with Micro Capillary Sample Mode Provides Major Blood-Saving Benefit

By LabMedica International staff writers
Posted on 05 Oct 2023
Print article
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)

Excessive blood collection for lab tests in critically ill patients is known to be a significant cause of severe anemia and increased use of blood products. This, in turn, leads to longer hospital stays and higher mortality rates. Now, a novel blood gas analyzer featuring a micro capillary sample mode provides a major blood-saving benefit for the diagnostic testing of critically ill patients.

Nova Biomedical (Waltham, MA, USA) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a micro capillary sample mode on its Stat Profile Prime Plus Critical Care analyzer. This new feature allows Prime Plus to perform an 11-test panel using only 90 microliters of capillary blood. Alternatively, a comprehensive 22-test profile can be done with just 135 microliters of blood. This sampling mode enhances Prime Plus's existing capabilities for conserving blood during diagnostic testing and is now a standard feature on all Prime Plus analyzers.

The Stat Profile Prime Plus boasts a state-of-the-art test menu for critical care, featuring a range of tests including pH, PCO2, PO2, SO2%, Na, K, iCa, iMg, Cl, TCO2, glucose, lactate, creatinine, urea, hematocrit, hemoglobin, MCHC, estimated plasma volume, CO-Oximetry panel, and 34 calculated results. The simple, compact analyzer uses maintenance-free, replaceable cartridges for sensors and reagents, along with patented, maintenance-free, whole blood CO-Oximetry technology. The device's ability to use small-volume microcapillary blood collection tubes eliminates sample over-draws, dead volume, and waste typically associated with syringe or vacuum tube methods. Moreover, Prime Plus allows for scheduled bundling of tests, reducing the number of times blood needs to be drawn as well as the variety of containers used, thereby minimizing blood drawn for critical care testing.

"Prime Plus microsample volume and comprehensive test menu provide a major blood-saving benefit for diagnostic testing of critically ill patients,” said Terry Austin, Sales Product Line Manager for Prime Plus analyzer. “Prime Plus delivers gases, electrolytes, glucose, lactate, hematocrit, or any subset of these tests on just two drops (90 microliters) of blood. A basic metabolic panel of electrolytes, glucose, lactate, creatinine, urea, and hematocrit is available on 135 microliters, 1/50th the volume of blood needed for the same tests in the central laboratory."

Related Links:
Nova Biomedical

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more